Parvovirus B19 infection in hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma

Thyroid

Volumn 21, Issue 4, 2011, Pages 411-417

  Adamson, Laura A ^a   Fowler, Larry J ^a   Clare Salzler, Michael J ^a   Hobbs, Jacqueline A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

ADENOMA; ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ANAPLASTIC THYROID CARCINOMA; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; ERYTHEMA INFECTIOSUM; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TISSUE; TOXIC GOITER;

CAPSID PROTEINS; CARCINOMA, PAPILLARY; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; THYROID GLAND; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE;

EID: 79954532695     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0307     Document Type: Article

References (35)

1. Heegaard ED, Brown KE 2002 Human parvovirus B19. Clin Microbiol Rev 15:485-505. (Pubitemid 34761354)
2. Young NS, Brown KE 2004 Parvovirus B19. N Engl J Med 350:586-597.
3. Douvoyiannis M, Litman N, Goldman DL 2009 Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis 48:1713-1723.
4. Hammond CJ, Hobbs JA 2007 Parvovirus B19 infection of brain: possible role of gender in determining mental illness and autoimmune thyroid disorders. Med Hypotheses 69: 113-116. (Pubitemid 46686946)
5. Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A 2008 Human parvovirus B19 infection and auto-immunity. Autoimmun Rev 8:116-120.
6. Munakata Y, Kodera T, Saito T, Sasaki T 2005 Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection. Lancet 366:780. (Pubitemid 41207242)
7. Wang J, Zhang W, Liu H, Wang D, Wang W, Li Y, Wang Z, Wang L, Zhang W, Huang G 2010 Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults. J Infect 60:360-370.
8. Lehmann HW, Lutterbuse N, Plentz A, Akkurt I, Albers N, Hauffa BP, Hiort O, Schoenau E, Modrow S 2008 Associa-tion of parvovirus B19 infection and Hashimoto's thyroiditis in children. Viral Immunol 21:379-383.
9. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshi-kawa S, Ozaki H, Ito S, Yoshida K 2007 Intrathyroidal per-sistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis. J Infect 55:29-31.
10. Vanacker J-M, Corbau R, Adelmant G, Perros M, Laudet V, Rommelaere J 1996 Transactivation of a cellular promoter by the NS1 protein of the parvovirus minute virus of mice through a putative hormone-responsive element. J Virol 70:2369-2377. (Pubitemid 26087600)
11. Vanacker J-M, Laudet V, Adelmant G, Stehelin D, Romme-laere J 1993 Interconnection between thyroid hormone sig-naling pathways and parvovirus cytotoxic functions. J Virol 67:7668-7672. (Pubitemid 23343902)
12. Fagin JA 2005 Molecular genetics of tumors of thyroid fol-licular cells. In: Braverman LE, Utiger RD (eds). Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott Williams & Wilkins, Philadelphia, PA, pp 906-927.
13. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng S-Y, Nauman J 2002 Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87:1120-1128. (Pubitemid 36121076)
14. Suzuki H, Willingham MC, Cheng SY 2002 Mice with a mutation in the thyroid hormone receptor beta gene spon-taneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12:963-969. (Pubitemid 35404130)
15. Nikiforov YE 2008 Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 21:S37-S43. (Pubitemid 351592770)
16. Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, Wang L, He FR, Wang Z, Yan QG, Chen LW, Huang GS 2008 Detection of human parvovirus B19 in papillary thy-roid. Br J Cancer 98:611-618. (Pubitemid 351214525)
17. Mazzaferri EL 2006 An overview of the management of thyroid cancer. In: Mazzaferri EL, Harmer C, Mallick UK, Kendall-Taylor P (eds) Practical Management of Thyroid Cancer: A Multidisciplinary Approach. Springer-Verlag, London, pp 1-28.
18. Smallridge RC, Copland JA 2010 Anaplastic thyroid carci-noma: pathogenesis and emerging therapies. Clin Oncol 22:486-497.
19. Henderson YC, Shellenberge, TD, William, MD, El-Nagga, AK, Fredric, MJ, Cieply KM, Clayman GL 2009 High rate of BRAF and RET/PTC dual mutations associated with recur-rent papillary thyroid carcinoma. Clin Cancer Res 15:485-491.
20. Pasieka JL 2003 Anaplastic thyroid cancer. Curr Opin Oncol 15:78-83. (Pubitemid 36135652)
21. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Giannini R, Salvatore G, Fusco A, San-toro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404. (Pubitemid 37452745)
22. Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X 2005 Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 103:2261-2268. (Pubitemid 40686569)
23. Sadahira Y, Sugihara T, Yawata Y 2001 Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection. Int J He-matol 74:147-152. (Pubitemid 33760064)
24. Asa SL 2004 My approach to oncocytic tumors of the thyroid (review). J Clin Pathol 57:225-232. (Pubitemid 38338828)
25. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hübinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Söderlund-Venermo M, Hedman K 2006 Bioportfolio: life-long persistence of variant and prototypic erythrovirus DNA genomes in human tissue. PNAS 103:7450-7453. (Pubitemid 43727853)
26. Bonvicini F, La Placa M, Manaresi E, Gallinella G, Gentilomi GA, Zerbini M, Musiani M 2010 Parvovirus B19 DNA is commonly harboured in human skin. Dermatology 220:138-142.
27. Grant JK, Yin NC, Zaytoun AM, Waseem H, Hobbs JA 2009 Persistent adeno-associated virus 2 and parvovirus B19 se-quences in post-mortem human cerebellum. Cerebellum 8:490-498.
28. Yaegashi N, Shiraishi H, Takeshita T, Nakamura M, Yajima A, Sugamura K 1989 Propagation of human parvovirus b19 in primary culture of erythroid linease cells derived from fetal liver. J Virol 63:2422-2426. (Pubitemid 19137513)
29. Diss TC, Pan LX, Du MQ, Peng HZ, Kerr JR 1999 Parvovirus B19 is associated with benign testes as well as testicular germ cell tumours. Mol Pathol 52:349-352. (Pubitemid 30002768)
30. Wang X, Zhang G, Liu F, Han M, Xu D, Zang Y 2004 Pre-valence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization. J Clin Virol 31:20-24. (Pubitemid 39024380)
31. Srivastava A, Lu L 1988 Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol 62:3059-3063.
32. Koduri PR 1998 Novel cytomorphology of the giant proer-ythroblasts of parvovirus B19 infection. Am J Hematol 58: 95-99. (Pubitemid 28268083)
33. Arif S, Blanes A, Diaz-Cano SJ 2002 Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 41:357-362. (Pubitemid 35279034)
34. Mousset S, Ouadrhiri Y, Caillet-Fauquet P, Rommelaere J 1994 The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells de-pends on oncogene expression. J Virol 68:6446-6453. (Pubitemid 24294894)
35. Spegelaere P, Van Hille B, Spruyt N, Faisst S, Cornelis JJ Rommelaere J 1991 Initiation of transcription from the minute virus of mice P4 promoter is stimulated in rat cells expressing a c-Ha-ras oncogene. J Virol 65:4919-4928.